Delivery Order 36F79724D0159-15B50926F00000099
Award Date 8/1/26
Potential Completion Date 8/31/26
Potential Value $62K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Titusville, Hopewell Township, NJ 08560, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Federal Correctional Institution Fort Worth awarded a delivery order valued at $61,988.37 to Actelion Pharmaceuticals US, Inc. for pharmaceutical supplies under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). This firm fixed-price delivery order, issued on September 1, 2026, with a completion date of September 30, 2026, procures Uptravi and Opsumit—specialized medications used to treat pulmonary arterial hypertension and related rare diseases. The order carries no small...
- The Federal Correctional Institution Fort Worth awarded a delivery order valued at $61,988.37 to Actelion Pharmaceuticals US, Inc. for pharmaceutical products Uptravi and Opsumit, effective July 1 through July 31, 2026. This is a firm fixed-price delivery order with no small business set-aside designation. The award is issued under Actelion's parent Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), a multiple-award schedule valued at $219.1 million with a performance...
- The Federal Correctional Institution Fort Worth awarded a delivery order to Actelion Pharmaceuticals US, Inc. on April 1, 2026, with a ceiling value of $61,988.37 and completion date of April 30, 2026. This firm fixed-price delivery order falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, a multiple-award schedule valued at $219.1 million with a performance period extending through July 31, 2029. The award carries no set-aside designation, and the ordering is...
- The Federal Correctional Institution Fort Worth awarded a delivery order valued at approximately $62K to Actelion Pharmaceuticals US, Inc. for pharmaceutical products Uptravi (selexipag) and Opsumit through a Firm Fixed Price contract with a completion date of May 31, 2026. This delivery order is a child contract issued under the parent Federal Supply Schedule 61-IB (Pharmaceuticals and Drugs) contract, which provides a streamlined procurement vehicle for federal agencies to order pre-negotiated...
- Actelion Pharmaceuticals US, Inc. has been awarded a delivery order valued at $61,988.37 under the FY26 Pharmacy March procurement, with an ultimate completion date of March 31, 2026. This firm fixed-price delivery order was issued by the Federal Correctional Institution Fort Worth on March 1, 2026, with no small business set-aside designation. The contract represents a continuation of pharmaceutical supply services under Actelion's existing Federal Supply Schedule contract (FSS-61-IB) for...
- The Department of Justice Bureau of Prisons Federal Correctional Institution Fort Worth awarded a $215,044.95 delivery order to Actelion Pharmaceuticals US, Inc. for the provision of medication for inmate use. This order was placed against Actelion's Federal Supply Schedule (FSS-61-IB) contract for Pharmaceuticals and Drugs, which allows federal agencies to procure needed prescription medications at pre-negotiated pricing. Actelion Pharmaceuticals is a for-profit organization that manufactures...
- Federal Medical Center Carswell issued a delivery order to Actelion Pharmaceuticals US, Inc. on March 1, 2026, for $12,853.56 to procure Opsumit 10mg tablets (quantity 2 units at $6,426.78 each) under a firm fixed-price arrangement. The ultimate completion date is March 31, 2026. Opsumit is a specialized pharmaceutical treatment for pulmonary arterial hypertension that Actelion supplies to federal healthcare facilities, including correctional institutions and veterans' medical centers. This...
- The Department of Justice Bureau of Prisons Federal Medical Center Carswell awarded a $36,202.48 firm fixed price delivery order contract to Actelion Pharmaceuticals US, Inc. for the provision of 30-count bottles of the pharmaceutical CURASCRIPT, OPSUMIT 10MG to treat pulmonary arterial hypertension. Actelion will deliver the medication under the Pharmaceuticals and Drugs General Services Administration Federal Supply Schedule contract, identified as Schedule 61-IB. Performance will occur from...
- The Department of Justice Bureau of Prisons Federal Medical Center Carswell awarded a $27,152 delivery order to Actelion Pharmaceuticals US, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule. The delivery order is for the medication Opsumit 10mg to be delivered to Carswell's location in Lake Mary, Florida. Actelion will provide the medication from August 2nd through August 31st of this year under the firm fixed price contract. The Bureau of Prisons operates federal medical...
- This federal contract was awarded by the Department of Justice Bureau of Prisons Federal Correctional Complex in Florence, Colorado to Actelion Pharmaceuticals US, Inc., a for-profit manufacturer of pharmaceutical products. The contract is a $9,774.67 Delivery Order for the medication OPSUMIT 10MG 30 CT and has a completion date of September 30, 2024. Actelion Pharmaceuticals US, Inc. holds a $105 million, five-year Federal Supply Schedule (FSS-61-IB) contract for Pharmaceuticals and Drugs, as...